Medicine by Design symposium panel explores strategies for strengthening Canada’s bioinnovation ecosystem
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges
Data generation, evidence of clinical effectiveness, cost and social values among the key considerations
International workshop tackles key policy questions around the adoption of regenerative medicine therapies
More than 40 academics, clinicians, policy-makers and industry leaders from Canada and the U.K. participated in the Challenges in the Adoption of Regenerative Medicine Therapies (CHART) workshop on June 24 and 25, 2019.